Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) | MicrobiomeTrials← Back to trialsNCT05913947
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2022-12-13Est. Completion: 2028-09-01
Enrollment target: 122 participants Locations- Aalborg University Hospital, Aalborg, Denmark
Other microbiome trials you might be interested in
Bipolar 1 Disorder
This is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. Th…
Little Rock, United StatesCompleted Aug 5, 2026
Mood DisordersSleep DisordersMigraine
This study will examine how depression, anxiety, and migraine run in families. It will help in defining the risk factors…
Bethesda, United States
Recruiting
At present, the treatment of Bipolar I disorder (BD-I), especially its depressive episode (bipolar depression), is still…
Taichung, TaiwanEst. completion Nov 2027